基本信息
views: 227
Career Trajectory
Bio
The aims of Dr. Oxnard’s research are to develop clinical applications for cancer genotyping technologies to advance precision cancer care.
Dr. Oxnard has published extensively on sensitivity and resistance to EGFR kinase inhibitors in lung cancer with a focus on the clinical biology of the EGFR T790M mutation. More recently his research has focused on genomic analysis of plasma cell-free DNA as a diagnostic to assist in treatment planning, response monitoring, and cancer detection.
Dr. Oxnard has published extensively on sensitivity and resistance to EGFR kinase inhibitors in lung cancer with a focus on the clinical biology of the EGFR T790M mutation. More recently his research has focused on genomic analysis of plasma cell-free DNA as a diagnostic to assist in treatment planning, response monitoring, and cancer detection.
Research Interests
Papers共 541 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
B. Miron, G. Li, J.C.F. Quintanilha, A. Clark, T. Scott, J.S. Ross,G.R. Oxnard, L.W. Pasquina,R.P. Graf,S. Gupta
ESMO Real World Data and Digital Oncology (2024): 100004-S1220
JOURNAL OF THORACIC ONCOLOGYno. 2 (2024): 227-239
crossref(2024)
Alessandro Russo,Jessica K Lee,Lincoln W Pasquina,Marzia Del Re, Holli H Dilks,Karthikeyan Murugesan,Russell W Madison,Yi Lee,Alexa B Schrock, Leah Comment, Martin Dietrich,Geoffrey R Oxnard,
JCO precision oncology (2024): e2300535-e2300535
Miles C Andrews,Gerald Li,Ryon P Graf,Virginia A Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke,Mark Shackleton,Mahesh Iddawela,Geoffrey R Oxnard,Richard S P Huang
JCO precision oncology (2024): e2300640-e2300640
crossref(2024)
LUNG CANCER (2024): 107454-107454
Cancer Researchno. 6_Supplement (2024): 971-971
crossref(2024)
crossref(2024)
Load More
Author Statistics
#Papers: 544
#Citation: 20517
H-Index: 64
G-Index: 139
Sociability: 8
Diversity: 0
Activity: 8
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn